Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

12871 ARTÍCULOS , VIENDO DEL 10066 AL 10080

Spinocerebellar degenerations

Perlman SL.

Handb Clin Neurol. 2011;100:113-40. doi: 10.1016/B978-0-444-52014-2.00006-9.

A modified Atkins diet is promising as a treatment for glucose transporter type 1 deficiency syndrome

Ito Y, Oguni H, Ito S, Oguni M, Osawa M.

Dev Med Child Neurol. 2011 Jul;53(7):658-63. doi: 10.1111/j.1469-8749.2011.03961.x. Epub 2011 Apr 18.

Xeroderma pigmentosum: a rare cause of chorea

Adamec D, Xie J, Poisson A, Broussolle E, Thobois S.

Rev Neurol (Paris). 2011 Nov;167(11):837-40. doi: 10.1016/j.neurol.2011.02.039. Epub 2011 Apr 22.

Dystonia in mitochondrial spinocerebellar ataxia and epilepsy syndrome associated with novel recessive POLG mutations

Hinnell C, Haider S, Delamont S, Clough C, Hadzic N, Samuel M.

Mov Disord. 2012 Jan;27(1):162-3. doi: 10.1002/mds.23960. Epub 2011 Sep 28.

Adult-onset cerebellar ataxia due to mutations in CABC1/ADCK3

Horvath R, Czermin B, Gulati S, Demuth S, Houge G, Pyle A, Dineiger C, Blakely EL, Hassani A, Foley C, Brodhun M, Storm K, Kirschner J, Gorman GS, Lochmüller H, Holinski-Feder E, Taylor RW, Chinnery PF.

J Neurol Neurosurg Psychiatry. 2012 Feb;83(2):174-8. doi: 10.1136/jnnp-2011-301258. Epub 2011 Oct 29.

Exome sequencing and SNP analysis detect novel compound heterozygosity in fatty acid hydroxylase-associated neurodegeneration

Pierson TM, Simeonov DR, Sincan M, Adams DA, Markello T, Golas G, Fuentes-Fajardo K, Hansen NF, Cherukuri PF, Cruz P, Mullikin JC, Blackstone C, Tifft C, Boerkoel CF, Gahl WA; NISC Comparative Sequencing Program.

Eur J Hum Genet. 2012 Apr;20(4):476-9. doi: 10.1038/ejhg.2011.222. Epub 2011 Dec 7.

Thiamine pyrophosphokinase deficiency in encephalopathic children with defects in the pyruvate oxidation pathway

Mayr JA, Freisinger P, Schlachter K, Rolinski B, Zimmermann FA, Scheffner T, Haack TB, Koch J, Ahting U, Prokisch H, Sperl W.

Am J Hum Genet. 2011 Dec 9;89(6):806-12. doi: 10.1016/j.ajhg.2011.11.007.

Association of micronucleus frequency with neurodegenerative diseases

Migliore L, Coppedè F, Fenech M, Thomas P.

Mutagenesis. 2011 Jan;26(1):85-92. doi: 10.1093/mutage/geq067.

Huntington’s Disease Pathogenesis: Mechanisms and Pathways

La Spada AR, Weydt P, Pineda VV.

In: Lo DC, Hughes RE, editors. Neurobiology of Huntington's Disease: Applications to Drug Discovery. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. Chapter 2.

Spinocerebellar ataxia type 2 is associated with Parkinsonism and Lewy body pathology

Takao M, Aoyama M, Ishikawa K, Sakiyama Y, Yomono H, Saito Y, Kurisaki H, Mihara B, Murayama S.

BMJ Case Rep. 2011 Apr 1;2011:bcr0120113685. doi: 10.1136/bcr.01.2011.3685.

Cerebrospinal fluid from patients with multiple system atrophy promotes in vitro α-synuclein fibril formation

Hirohata M, Ono K, Morinaga A, Ikeda T, Yamada M.

Neurosci Lett. 2011 Mar 10;491(1):48-52. doi: 10.1016/j.neulet.2011.01.005. Epub 2011 Jan 6.

Modelling progressive autonomic failure in MSA: where are we now?

Stemberger S, Wenning GK.

J Neural Transm (Vienna). 2011 May;118(5):841-7. doi: 10.1007/s00702-010-0576-3. Epub 2011 Jan 8.

The potential application of iron chelators for the treatment of neurodegenerative diseases

Hider RC, Roy S, Ma YM, Le Kong X, Preston J.

Metallomics. 2011 Mar;3(3):239-49. doi: 10.1039/c0mt00087f. Epub 2011 Feb 22.

Cytoplasmic dynein in neurodegeneration

Eschbach J, Dupuis L.

Pharmacol Ther. 2011 Jun;130(3):348-63. doi: 10.1016/j.pharmthera.2011.03.004. Epub 2011 Mar 21.

SUMO and its role in human diseases

Sarge KD, Park-Sarge OK.

Int Rev Cell Mol Biol. 2011;288:167-83. doi: 10.1016/B978-0-12-386041-5.00004-2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias